Profiel
Sondra S.
Newman is currently the Global Head-Investor Relations at Repligen Corp.
Prior to this, she worked as the Director-Investor Relations at NitroMed, Inc.
Actieve functies van Sondra S. Newman
| Bedrijven | Functie | Begin |
|---|---|---|
| REPLIGEN CORPORATION | Investor Relations Contact | - |
Eerdere bekende functies van Sondra S. Newman
| Bedrijven | Functie | Einde |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
